Human Cytomegalovirus-Induces Cytokine Changes in the Placenta with Implications for Adverse Pregnancy Outcomes

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Hamilton, Stuart T ^a,b   Scott, Gillian ^a,b   Naing, Zin ^a,b   Iwasenko, Jenna ^a,b   Hall, Beverley ^a   Graf, Nicole ^c   Arbuckle, Susan ^c   Craig, Maria E ^a,b,c   Rawlinson, William D ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADVERSE OUTCOME; ARTICLE; CHORION VILLUS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS INFECTION; EX VIVO STUDY; EXPLANT; FETUS; FETUS DEATH; FETUS DEVELOPMENT; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; IMMUNE DYSREGULATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; PLACENTA; PLACENTA DEVELOPMENT; PLACENTA DISORDER; PLACENTA FUNCTION; PREGNANCY OUTCOME; PROTEIN EXPRESSION; STILLBIRTH; TISSUE CULTURE; TISSUE LEVEL; UPREGULATION; VIRUS STRAIN;

CELLS, CULTURED; CHEMOKINE CCL2; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; STILLBIRTH; TISSUE CULTURE TECHNIQUES; TROPHOBLASTS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5;

EID: 84871809875     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052899     Document Type: Article

References (51)

1. Kenneson A, Cannon MJ, (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17: 253-276.
2. Nigro G, Adler SP, (2011) Cytomegalovirus infections during pregnancy. Curr Opin Obstet Gynecol 23: 123-128.
3. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA, (1992) Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11: 93-99.
4. Dollard SC, Grosse SD, Ross DS, (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17: 355-363.
5. Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM, (2002) Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 57: 245-256.
6. Iwasenko JM, Howard J, Arbuckle S, Graf N, Hall B, et al. (2011) Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. J Infect Dis 203: 1526-1533.
7. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, et al. (1986) Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 256: 1904-1908.
8. Wang C, Zhang X, Bialek S, Cannon MJ, (2011) Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis 52: e11-13.
9. Fisher S, Genbacev O, Maidji E, Pereira L, (2000) Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol 74: 6808-6820.
10. Maidji E, Genbacev O, Chang HT, Pereira L, (2007) Developmental regulation of human cytomegalovirus receptors in cytotrophoblasts correlates with distinct replication sites in the placenta. J Virol 81: 4701-4712.
11. Gabrielli L, Bonasoni MP, Lazzarotto T, Lega S, Santini D, et al. (2009) Histological findings in foetuses congenitally infected by cytomegalovirus. J Clin Virol 46Suppl 4: S16-21.
12. Trincado DE, Munro SC, Camaris C, Rawlinson WD, (2005) Highly sensitive detection and localization of maternally acquired human cytomegalovirus in placental tissue by in situ polymerase chain reaction. J Infect Dis 192: 650-657.
13. Maidji E, Nigro G, Tabata T, McDonagh S, Nozawa N, et al. (2010) Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am J Pathol 177: 1298-1310.
14. McEwan M, Lins RJ, Munro SK, Vincent ZL, Ponnampalam AP, et al. (2009) Cytokine regulation during the formation of the fetal-maternal interface: focus on cell-cell adhesion and remodelling of the extra-cellular matrix. Cytokine Growth Factor Rev 20: 241-249.
15. Powers C, DeFilippis V, Malouli D, Fruh K, (2008) Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 325: 333-359.
16. van de Berg PJ, Heutinck KM, Raabe R, Minnee RC, Young SL, et al. (2010) Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. J Infect Dis 202: 690-699.
17. Scott GM, Chow SS, Craig ME, Pang CN, Hall B, et al. (2012) Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid. J Infect Dis 205: 1305-1310.
18. Briana DD, Boutsikou M, Baka S, Papadopoulos G, Gourgiotis D, et al. (2007) Perinatal plasma monocyte chemotactic protein-1 concentrations in intrauterine growth restriction. Mediators Inflamm 2007: 65032.
19. Renaud SJ, Sullivan R, Graham CH, (2009) Tumour necrosis factor alpha stimulates the production of monocyte chemoattractants by extravillous trophoblast cells via differential activation of MAPK pathways. Placenta 30: 313-319.
20. Goser S, Ottl R, Brodner A, Dengler TJ, Torzewski J, et al. (2005) Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation 112: 3400-3407.
21. Haider S, Knofler M, (2009) Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta 30: 111-123.
22. Chaiworapongsa T, Romero R, Tolosa JE, Yoshimatsu J, Espinoza J, et al. (2002) Elevated monocyte chemotactic protein-1 in amniotic fluid is a risk factor for pregnancy loss. J Matern Fetal Neonatal Med 12: 159-164.
23. Renaud SJ, Postovit LM, Macdonald-Goodfellow SK, McDonald GT, Caldwell JD, et al. (2005) Activated macrophages inhibit human cytotrophoblast invasiveness in vitro. Biol Reprod 73: 237-243.
24. Toder V, Fein A, Carp H, Torchinsky A, (2003) TNF-alpha in pregnancy loss and embryo maldevelopment: a mediator of detrimental stimuli or a protector of the fetoplacental unit? J Assist Reprod Genet 20: 73-81.
25. Lopez H, Benard M, Saint-Aubert E, Baron M, Martin H, et al. (2011) Novel model of placental tissue explants infected by cytomegalovirus reveals different permissiveness in early and term placentae and inhibition of indoleamine 2,3-dioxygenase activity. Placenta 32: 522-530.
26. Robbins JR, Skrzypczynska KM, Zeldovich VB, Kapidzic M, Bakardjiev AI, (2010) Placental syncytiotrophoblast constitutes a major barrier to vertical transmission of Listeria monocytogenes. PLoS Pathog 6: e1000732.
27. Cheeran MC, Hu S, Yager SL, Gekker G, Peterson PK, et al. (2001) Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications. J Neurovirol 7: 135-147.
28. Chan G, Guilbert LJ, (2006) Ultraviolet-inactivated human cytomegalovirus induces placental syncytiotrophoblast apoptosis in a Toll-like receptor-2 and tumour necrosis factor-alpha dependent manner. J Pathol 210: 111-120.
29. Vince G, Shorter S, Starkey P, Humphreys J, Clover L, et al. (1992) Localization of tumour necrosis factor production in cells at the materno/fetal interface in human pregnancy. Clin Exp Immunol 88: 174-180.
30. Steinborn A, von Gall C, Hildenbrand R, Stutte HJ, Kaufmann M, (1998) Identification of placental cytokine-producing cells in term and preterm labor. Obstet Gynecol 91: 329-335.
31. Dargan DJ, Douglas E, Cunningham C, Jamieson F, Stanton RJ, et al. (2010) Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. J Gen Virol 91: 1535-1546.
32. Katabuchi H, Yih S, Ohba T, Matsui K, Takahashi K, et al. (2003) Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells. Med Electron Microsc 36: 253-262.
33. Esplin MS, Peltier MR, Hamblin S, Smith S, Fausett MB, et al. (2005) Monocyte chemotactic protein-1 expression is increased in human gestational tissues during term and preterm labor. Placenta 26: 661-671.
34. Garcia-Lloret MI, Winkler-Lowen B, Guilbert LJ, (2000) Monocytes adhering by LFA-1 to placental syncytiotrophoblasts induce local apoptosis via release of TNF-alpha. A model for hematogenous initiation of placental inflammations. J Leukoc Biol 68: 903-908.
35. Sadowsky DW, Adams KM, Gravett MG, Witkin SS, Novy MJ, (2006) Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol 195: 1578-1589.
36. Gendron RL, Nestel FP, Lapp WS, Baines MG, (1990) Lipopolysaccharide-induced fetal resorption in mice is associated with the intrauterine production of tumour necrosis factor-alpha. J Reprod Fertil 90: 395-402.
37. Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin JD, et al. (2004) Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab 89: 812-822.
38. Huber AV, Saleh L, Bauer S, Husslein P, Knofler M, (2006) TNFalpha-mediated induction of PAI-1 restricts invasion of HTR-8/SVneo trophoblast cells. Placenta 27: 127-136.
39. Chan G, Stinski MF, Guilbert LJ, (2004) Human cytomegalovirus-induced upregulation of intercellular cell adhesion molecule-1 on villous syncytiotrophoblasts. Biol Reprod 71: 797-803.
40. Lockwood CJ, Oner C, Uz YH, Kayisli UA, Huang SJ, et al. (2008) Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells. Biol Reprod 78: 1064-1072.
41. Leisser C, Saleh L, Haider S, Husslein H, Sonderegger S, et al. (2006) Tumour necrosis factor-alpha impairs chorionic gonadotrophin beta-subunit expression and cell fusion of human villous cytotrophoblast. Mol Hum Reprod 12: 601-609.
42. Maidji E, McDonagh S, Genbacev O, Tabata T, Pereira L, (2006) Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol 168: 1210-1226.
43. Koi H, Zhang J, Makrigiannakis A, Getsios S, MacCalman CD, et al. (2002) Syncytiotrophoblast is a barrier to maternal-fetal transmission of herpes simplex virus. Biol Reprod 67: 1572-1579.
44. Koi H, Zhang J, Parry S, (2001) The mechanisms of placental viral infection. Ann N Y Acad Sci 943: 148-156.
45. Yamamoto-Tabata T, McDonagh S, Chang HT, Fisher S, Pereira L, (2004) Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J Virol 78: 2831-2840.
46. Bilban M, Tauber S, Haslinger P, Pollheimer J, Saleh L, et al. (2010) Trophoblast invasion: assessment of cellular models using gene expression signatures. Placenta 31: 989-996.
47. Carter AM (2007) Animal models of human placentation-a review. Placenta 28 Suppl A: S41-47.
48. Jurak I, Brune W, (2006) Induction of apoptosis limits cytomegalovirus cross-species infection. EMBO J 25: 2634-2642.
49. Tabata T, Petitt M, Fang-Hoover J, Rivera J, Nozawa N, et al. (2012) Cytomegalovirus Impairs Cytotrophoblast-Induced Lymphangiogenesis and Vascular Remodeling in an in Vivo Human Placentation Model. Am J Pathol.
50. Stanton RJ, Baluchova K, Dargan DJ, Cunningham C, Sheehy O, et al. (2010) Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J Clin Invest 120: 3191-3208.
51. Faye A, Pornprasert S, Dolcini G, Ave P, Taieb J, et al. (2005) Evaluation of the placental environment with a new in vitro model of histocultures of early and term placentae: determination of cytokine and chemokine expression profiles. Placenta 26: 262-267.